Form4insider filings, from the source

SEC Form 4 · accession 0000950142-16-004060

Syros Pharmaceuticals, Inc. · SYRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Steve Elms
10% Owner
Period of report
Jul 6, 2016
Accepted (ET)
Jul 6, 2016 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 6, 2016C508,565—A508,565D
Common StockF2Jul 6, 2016P400,000$12.50A908,565D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1—Jul 6, 2016C1,907,122D——Common Stock508,5650D

Explanation of responses